SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-14-003376
Filing Date
2014-03-05
Accepted
2014-03-04 17:51:07
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K insy20131231_10k.htm 10-K 1826888
2 EXHIBIT 23.1 ex23-1.htm EX-23 5622
3 EXHIBIT 31.1 ex31-1.htm EX-31 16894
4 EXHIBIT 31.2 ex31-2.htm EX-31 16923
5 EXHIBIT 32 ex32.htm EX-32 9230
12 pic1.jpg GRAPHIC 18117
  Complete submission text file 0001437749-14-003376.txt   7571017

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS insy-20131231.xml EX-101.INS 986116
7 EXHIBIT 101.SCH insy-20131231.xsd EX-101.SCH 49743
8 EXHIBIT 101.CAL insy-20131231_cal.xml EX-101.CAL 47322
9 EXHIBIT 101.DEF insy-20131231_def.xml EX-101.DEF 273859
10 EXHIBIT 101.LAB insy-20131231_lab.xml EX-101.LAB 432908
11 EXHIBIT 101.PRE insy-20131231_pre.xml EX-101.PRE 274373
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35902 | Film No.: 14666440
SIC: 2834 Pharmaceutical Preparations